Aescin is derived from the seeds of the historically used horse chestnut (Aesculus hippocastanum L.) and utilizes modern extraction and purification technologies to achieve high purity and standardization. As a naturally derived active substance, Horse chesnut seed extract aescin has attracted widespread attention in the medical and scientific communities due to its diverse pharmacological properties.
In clinical applications, aescin has established a definite therapeutic position in the treatment of chronic venous insufficiency (CVI), hemorrhoids, postoperative edema, and other diseases, becoming a natural drug choice in the treatment of venous diseases. Research into its multi-target mechanism of action at the molecular level, including anti-inflammatory, vascular protective, and antioxidant effects, is needed to better understand its application potential.
KINTAIBIO®'s Aescin Extract Powder is a high-purity plant-based active ingredient. This product is available in three strengths with Aesculus Hippocastanum Extract aescin content of 20%, 40%, and 98%, including 98% sodium aescinate and 40% water-soluble aescin, to meet various application needs. If needed, please contact sales@kintaibio.com
Aescin Mechanism of Action
Aescin's Anti-inflammatory Mechanism
Aescin inhibits the activity of cyclooxygenase (COX) and lipoxygenase (LOX), reducing the synthesis of pro-inflammatory mediators such as prostaglandins and leukotrienes. At the molecular level, it reduces the release of inflammatory cytokines such as TNF-α and IL-6 by inhibiting IκB kinase (IKK) activation and blocking NF-κB nuclear translocation.
Recent studies have found that aescin plays a key role in anti-edema and neuroprotection by downregulating the expression of pro-inflammatory factors through inhibiting the NF-κB/NLRP3 signaling pathway. In an atopic dermatitis model, Horse Chestnut Extract aescin significantly reduced immunoglobulin E levels and mast cell infiltration; part of its anti-inflammatory effect is mediated by glucocorticoid receptors. A 2023 study also found that aescin can improve inflammation by inhibiting Piezo1 activation in vascular endothelial cells, explaining its efficacy in hemodynamically related diseases such as varicose veins.
Source: https://www.mdpi.com
Aescin's Mechanism of Vascular Protection
Regarding venous tone regulation, aescin increases venous contractile tone by regulating ion channels in vascular smooth muscle cells, promoting calcium ion influx. It also stimulates the release of prostaglandin F2α (PGF2α) from the venous wall, further enhancing the venous contractile effect.Aescin promotes calcium ion influx into endothelial cells, activates contractile proteins, and narrows intercellular spaces, thereby reducing plasma protein and water leakage, decreasing pathological capillary permeability, and accelerating edema resolution.
Aescin Extract Powder inhibits hyaluronidase and elastase, protecting capillary wall integrity and reducing the risk of microvascular rupture. In a hypoxic endothelial cell model, aescin pretreatment prevents increased VCAM-1 expression and decreased PECAM-1 expression, maintaining normal endothelial cell morphology.
Source:https://www.sciencedirect.com/
Aescin's Antioxidant Mechanism
Aescin possesses direct free radical scavenging capabilities, directly neutralizing reactive oxygen species and superoxide anions, and blocking the lipid peroxidation chain reaction. More importantly, it can activate the Nrf2-ARE pathway, a cellular endogenous antioxidant defense system. A 2023 study first discovered that aescin can activate antioxidants and autophagy through the Keap1-Nrf2 pathway, improving lipid accumulation and oxidative stress in non-alcoholic fatty liver disease (NAFLD).
Computer simulations show that Horse chesnut seed extract aescin may interact with Keap1, promoting Nrf2 translocation into the nucleus to exert its function. In skin care, aescin helps delay UV-induced photoaging by reducing oxidative stress damage to collagen and elastin fibers, and inhibits the activation of matrix metalloproteinases-1 (MMP-1), thereby maintaining skin elasticity.
Aescin Receptor Antagonism
Aescin also exhibits antagonistic effects against various vasoactive substances. It can antagonize the effects of serotonin (5-HT) and histamine on blood vessels, which is one of the bases for its anti-inflammatory and anti-allergic properties. By blocking the vascular effects of these inflammatory mediators, Aescin Extract Powder can further alleviate inflammatory responses and allergic symptoms.
Aescin's Mechanism of Enhancing Transdermal Absorption
As a natural saponin surfactant, aescin possesses unique properties that enhance transdermal absorption. It can temporarily disrupt the lipid bilayer structure of the stratum corneum, increasing the fluidity of intercellular lipids. Specifically, its hydrophobic aglycone inserts into intercellular lipids, while the hydrophilic glycans interact with polar molecules to form hydrophilic channels, thereby promoting the transdermal absorption of macromolecular active ingredients such as peptides and polysaccharide antioxidants.
Research data shows that adding 0.5% aescin can increase the skin permeability of quercetin by 1.8 times while maintaining the integrity of the stratum corneum barrier. This property makes Aesculus Hippocastanum Seed Extract aescin not only therapeutically valuable but also a functional penetration enhancer, improving the bioavailability of other active ingredients, and has significant application value in the development of transdermal drug delivery systems and functional skincare products.
Exploring Novel Antitumor Mechanisms of Aescin
A recent study published in 2025 provides new insights into the antitumor potential of Aescin Extract Powder. Studies have found that aescin promotes pyroptosis in breast cancer cells by stimulating reactive oxygen species (ROS) levels and activating the Caspase-1/GSDMD signaling pathway. Pyroptosis is a programmed cell death mechanism with a strong immune-activating effect.
Experimental data showed that, compared with the control group, the aescin-treated group had significantly increased ROS levels and pyroptosis rate, decreased FL-GSDMD and pro-Caspase-1 protein expression, and increased N-GSDMD, cleaved Caspase-1, and IL-18 protein expression. These effects were reversed after pretreatment with the ROS scavenger NAC, confirming the crucial role of ROS in this pathway. This finding opens up new research directions for the application of aescin in adjuvant cancer therapy.
Reference:https://pubmed.ncbi.nlm.nih.gov/11529685/
https://www.sciencedirect.com/science/article/abs/pii/S0944711323001046?via%3Dihub
The Synergistic Mechanism of Action of Aescin
The therapeutic effect of Aescin Extract Powder stems from the synergistic integration of its multi-target effects. The three core mechanisms of anti-inflammation, angiogenesis protection, and antioxidation intertwine to form a positive feedback loop.
Anti-inflammatory effects reduce inflammatory damage to vascular endothelial cells, indirectly protecting vascular function; vascular protection maintains normal microcirculation perfusion, preventing oxidative stress caused by ischemia-reperfusion; and antioxidant effects scavenge excess free radicals generated during inflammation, mitigating the vicious cycle of inflammatory response.
In recent years, research on aescin has continuously expanded its application boundaries, extending from classic treatment of intravenous diseases to atopic dermatitis, non-alcoholic fatty liver disease, traumatic brain injury, and even adjuvant cancer therapy. In particular, the discovery of novel targets such as the NLRP3 inflammasome, Piezo1 channel, and Nrf2 pathway provides a theoretical basis for the application of Aesculus Hippocastanum Seed Extract in a wider range of diseases.
Aescin Safety and Clinical Application Precautions
- Aescin is well-tolerated clinically. Common adverse reactions include mild gastrointestinal discomfort such as nausea and stomach upset. Rare adverse reactions include hypersensitivity reactions such as urticaria, with an incidence of less than one in ten thousand.
- Regarding contraindications, aescin is contraindicated in patients with renal insufficiency, renal failure, or nephropathy, as it may increase the burden on the kidneys. Conversely, Horse Chestnut Extract aescin should not be used in patients with known hypersensitivity to any of its components.
- Regarding drug interactions, close monitoring is necessary when aescin is used concurrently with anticoagulants such as warfarin. Concomitant use with aminoglycoside antibiotics such as gentamicin should be avoided, as their nephrotoxicity may be enhanced. Furthermore, antibiotics may affect the binding of aescin to plasma proteins, increasing the risk of adverse reactions.
- Regarding use in special populations, aescin is not recommended for pregnant or breastfeeding women.
Where to buy aescin Powder?
Aesculus Hippocastanum Seed Extract Aescin establishes its cornerstone position in the field of vascular protection through a multi-target mechanism encompassing venous constriction, capillary protection, anti-inflammation, and antioxidation. Its effects involve multiple levels, including ion channel regulation, inhibition of inflammatory signaling pathways, and activation of antioxidant enzyme systems, forming a complete pharmacological network.
As a professional Aescin Extract Powder manufacturer, we are committed to providing high-purity, highly stable Aescin Extract Powder raw materials. We are excited to cooperate with you as a supplier of Horse Chestnut Extract. We are dedicated to providing you with a top-quality product that meets industry standards and regulatory requirements. If you'd like further details about Horse Chestnut Extract Powder, feel free to contact us at sales@kintaibio.com.
